Stryker (NYSE:SYK) said yesterday it completed a simplified public tender offer for French spinal implant maker Vexim, giving the company a 92.2% stake of its share capital and 91.6% of its voting rights. The tender offer, opened Nov. 16 to Dec. 6, followed plans the company released in October to acquire the company in a deal […]
Vexim
Stryker to acquire French spinal implant maker Vexim for $216m
Stryker (NYSE:SYK) yesterday acquired a majority stake in Vexim for roughly $216 million and plans to buy the rest of the French spinal implant maker today. Kalamazoo, Mich.-based Stryker paid €20 ($23.63) per share for Vexim’s stock and €3.91 ($4.62) per listed warrant, for a total equity value of €183 million, Vexim said. The deal is expected to close […]
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
Medtronic vet takes over marketing at Vexim | Personnel Moves
Welch Allyn CEO Julie Shimer to retire | Personnel Moves
Welch Allyn president & CEO Julie Shimer announced plans to retire from the Skaneateles Falls, N.Y.-based diagnostics maker by the end of 2012.
Shimer became the first woman to hold the corner office at the 95-year old company when she took the position in 2007 after 5 years on the med-tech maker’s board of directors.
Optos gains on Project Daytona FDA clearance | MassDevice.com Regulatory Roundup
Shares of Optos plc (LSE:OPTS) gained 6.4 percent after the company announced that the FDA granted 510(k) clearance in the U.S. for its Project Daytona retinal scanning device.
The British ophthalmology device maker’s stock closed at £1.62 today (about $2.64), up about 15 cents since August 25, the day before the clearance announcement, when OPTS shares closed at £1.52 ($2.49) on the London Stock Exchange.